12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's pre-market session, several health care stocks experienced significant movements. AEterna Zentaris, Accelerate Diagnostics, Akero Therapeutics, Regulus Therapeutics, Atara Biotherapeutics, and Redhill Biopharma saw notable gains, while AIkido Pharma, T2 Biosystems, Biolase, AzurRx BioPharma, InVivo Therapeutics, and Celsion experienced declines.
January 27, 2021 | 1:11 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AEterna Zentaris shares rose 20.97% to $0.82, increasing its market cap to $51.4 million.
AEterna Zentaris experienced a significant price increase, indicating positive market sentiment or news. This could attract short-term investors looking for momentum plays.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Akero Therapeutics stock rose 9.96% to $33.0, with a market cap of $1.1 billion.
Akero Therapeutics' stock price increase indicates positive investor sentiment, potentially due to favorable news or market conditions.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Atara Biotherapeutics shares rose 8.38% to $21.2, with a market cap of $1.7 billion.
Atara Biotherapeutics' stock price increase indicates positive investor sentiment, likely due to favorable news or market conditions.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Accelerate Diagnostics stock moved up 16.58% to $13.99, with a market cap of $797.8 million.
The significant rise in AXDX's stock price suggests positive developments or investor interest, likely leading to short-term gains.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Redhill Biopharma shares increased by 7.41% to $8.98, with a market cap of $373.4 million.
The increase in RDHL's stock price suggests positive market sentiment, possibly due to recent developments or investor interest.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Regulus Therapeutics stock increased by 9.67% to $1.7, with a market cap of $113.7 million.
The rise in RGLS's stock price suggests positive market sentiment, possibly due to recent developments or investor interest.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
AIkido Pharma stock decreased by 17.88% to $1.47, with a market cap of $51.3 million.
AIkido Pharma's significant stock price drop indicates negative market sentiment, possibly due to unfavorable news or developments.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
AzurRx BioPharma shares decreased by 14.58% to $1.7, with a market cap of $58.3 million.
The decline in AZRX's stock price suggests negative investor sentiment, likely due to unfavorable news or market conditions.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Biolase stock decreased by 14.67% to $1.28, with a market cap of $160.1 million.
Biolase's stock price drop indicates negative market sentiment, possibly due to unfavorable news or developments.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Celsion shares decreased by 12.36% to $1.56, with a market cap of $58.3 million.
The decline in CLSN's stock price suggests negative investor sentiment, likely due to unfavorable news or market conditions.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
InVivo Therapeutics shares declined by 13.05% to $1.4, with a market cap of $29.6 million.
InVivo Therapeutics' stock price drop indicates negative market sentiment, possibly due to unfavorable news or developments.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
T2 Biosystems stock fell 17.44% to $2.32, with a market cap of $343.2 million.
The decline in TTOO's stock price suggests negative investor sentiment, likely due to unfavorable news or market conditions.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80